03-0056: BUPROPION HYDROCHLORIDE TABLETS.
BUPROPION HYDROCHLORIDE TABLETS. Key specifications include administration: ORAL, coating_feature: FILM, NONENTERIC, long_action_method: EXTENDED RELEASE, primary_container_type: BOTTLE, supplementary_features: ADVANTAGE PACK, INCLUDES BT. AND PATIENT BOOKLET, primary_container_content_quantity: 60.000 TABLETS.
This part is cataloged in the U.S. Government catalog under NSN 6230-01-373-7611, indicating validated use in U.S. government and defense logistics supply chains.
Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels. Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| coating_feature | FILM, NONENTERIC |
| special_features | TO HELP WITH A PLAN TO QUIT SMOKING; STORE AT CONTROLLED ROOM TEMP.; DISPENSE IN TIGHT, LIGHT-RESISTANT CONTAINERS; SUSTAINED-RELEASED TABLETS; BOX CONTAINS 1 BOTTLE WITH PATIENT BOOKLET/INSTRUCTIONS |
| long_action_method | EXTENDED RELEASE |
| primary_container_type | BOTTLE |
| supplementary_features | ADVANTAGE PACK, INCLUDES BT. AND PATIENT BOOKLET |
| total_primary_container_quantity | 1 |
| primary_container_content_quantity | 60.000 TABLETS |
| active_medicament_medicinal_strength | 150.000 MILLIGRAMS BUPROPION HYDROCHLORIDE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | BUPROPION HYDROCHLORIDE ZYBAN ADVANTAGE PACK BT 150MG 60 TABS INCLUDES PATIENT BOOKLET |
| american_hospital_formulary_service_classification_number | 281604 |
| NSN | 6230-01-373-7611 |
No substitute or cross-reference records for this part.